

HY-15882 · 50 mg
MedChemExpress · Cat: HY-15882
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/gne-783.html
Description
GNE-783 is a selective CHK1 inhibitor that enhances the activity of gemcitabine. GNE-783 improves the efficacy of anti-metabolite DNA damage drugs by inactivating S-phase and G2-phase cell cycle checkpoints following DNA damage. GNE-783 selectively enhances the chemical synergy of certain drugs in different tumor types, for example, enhancing the activity of temozolomide only in melanoma cell lines.







